PD-L1 mediates dysfunction in activated PD-1+ NK cells in head and neck cancer patients - Concha-Benavente, F; Kansy, B; Moskovitz, J; Moy, J; Chandran, U; Ferris, R L (Cancer Immunol Res, 2018)